References
- Hanash S. Disease proteomics. Nature422(6928), 226–232 (2003).
- Borrebaeck CA, Wingren C. High-throughput proteomics using antibody microarrays: an update. Expert Rev. Mol. Diagn.7(5), 673–686 (2007).
- Cho WC. Proteomics technologies and challenges. Genomics Proteomics Bioinformatics5(2), 77–85 (2007).
- Cravatt BF, Simon GM, Yates JR 3rd. The biological impact of mass-spectrometry-based proteomics. Nature450(7172), 991–1000 (2007).
- Hanash SM, Pitteri SJ, Faca VM. Mining the plasma proteome for cancer biomarkers. Nature452(7187), 571–579 (2008).
- Cho WC. Contribution of oncoproteomics to cancer biomarker discovery. Mol. Cancer6, 25 (2007).
- Hu S, Loo JA, Wong DT. Human body fluid proteome analysis. Proteomics6(23), 6326–6353 (2006).
- Gerszten RE, Accurso F, Bernard GR et al. Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs. Am. J. Physiol.295(1), L16–L22 (2008).
- Mischak H, Apwiler R, Banks RE et al. Clinical proteomics: a need to define the field and begin to set adequate standards. Clin. Proteomics1, 148–156 (2007).
- Muller GA, Muller CA, Dihazi H. Clinical proteomics – on the long way from bench to bedside? Nephrol. Dial. Transplant,22(5), 1297–1300 (2007).
- Kovarova H, Gadher S. Quest for a new generation of biomarkers using quantitative proteomics. Eur. Pharmaceutical Rev.5, 24–27 (2008).
- Beretta L. Proteomics from the clinical perspective: many hopes and much debate. Nat. Methods4(10), 785–786 (2007).
- Duncan MW, Hunsucker SW. Proteomics as a tool for clinically relevant biomarker discovery and validation. Exp. Biol. Med.230(11), 808–817 (2005).
- Good DM, Thongboonkerd V, Novak J et al. Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J. Proteome Res.6(12), 4549–4555 (2007).
- Cordero OJ, De Chiara L, Lemos-Gonzalez Y, Paez de la Cadena M, Rodriguez-Berrocal FJ. How the measurements of a few serum markers can be combined to enhance their clinical values in the management of cancer. Anticancer Res.28(4C), 2333–2341 (2008).
- Omenn GS, States DJ, Adamski M et al. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics5(13), 3226–3245 (2005).
- Lescuyer P, Hochstrasser D, Rabilloud T. How shall we use the proteomics toolbox for biomarker discovery? J. Proteome Res.6(9), 3371–3376 (2007).